Evidence map›Paper›PMID 38547469›Full record

ArticleAmerican journal of public health2024

Qualitative Evaluation of RADx-UP Projects Addressing COVID-19 Testing Disparities Among Underserved Populations.

Shelly A Maras, Abisola Osinuga, Iñigo Verduzco Gallo, Arturo Rodriguez, Erin Corriveau, Kelley Milligan, Allyson Kelley, Tara Carr, Gaurav Dave

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shelly A MarasShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Abisola OsinugaShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Iñigo Verduzco GalloShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Arturo RodriguezShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Erin CorriveauShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Kelley MilliganShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Allyson KelleyShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Tara CarrShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.
Gaurav DaveShelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.

Funding

RADx-UP SAY YES COVID Test Study (S4)U24MD016258 · NIMHD · DUKE UNIVERSITY · PI COHEN-WOLKOWIEZ, MICHAEL, DAVE, GAURAV J · 2020 to 2023
$116.7M
UC Davis Environmental Health Sciences Core CenterP30ES023513 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Irva Hertz-Picciotto · 2015 to 2026
$26.0M
NIEHS NIH HHS P30 ES023513NIMHD NIH HHS U24 MD016258
6 · The paper itself

Abstract

In this article, we present findings from a May 2022 to March 2023 qualitative evaluation of Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) projects addressing COVID-19 testing disparities among underserved populations. Interviews with academic and community partners from 13 RADx-UP projects revealed that despite the pandemic, projects were able to build trust and relationships with underserved populations. By prioritizing community voices during a public health emergency, RADx-UP projects improved health equity and pandemic preparedness in these communities, successfully conducted community-engaged research, and built long-lasting community partnerships. (

Indexed as

COVID-19COVID-19 TestingVulnerable PopulationsHealthcare DisparitiesHumansPandemicsQualitative ResearchSARS-CoV-2

Identifiers

PMID38547469
PMCPMC11111372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.